# CONCERT PHARMACEUTICALS, INC.

CONCERT PHARMACEUTICALS, INC. is a company headquartered in Lexington, MA, United States.

## Company overview

- **Legal name:** CONCERT PHARMACEUTICALS, INC.
- **Former names in filing history:** CONCERT PHARMACEUTICALS INC (2006-06-16 to 2008-05-09)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Lexington, MA, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001367920

## About

CONCERT PHARMACEUTICALS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001367920, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-03-03, it reported annual revenue of USD 32,578,000; net income of USD -80,051,000; total assets of USD 165,316,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $32.6M (USD 32,578,000)
- **Net income:** -$80.1M (USD -80,051,000)
- **Total assets:** $165.3M (USD 165,316,000)
- **Cash and equivalents:** $141.6M (USD 141,636,000)
- **Operating cash flow:** -$55.2M (USD -55,154,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $7.9M (USD 7,902,000)
- **Net income:** -$74.8M (USD -74,766,000)
- **Total assets:** $159.3M (USD 159,263,000)
- **Cash and equivalents:** $77.2M (USD 77,202,000)
- **Operating cash flow:** -$69.0M (USD -69,037,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $1.1M (USD 1,077,000)
- **Net income:** -$78.2M (USD -78,166,000)
- **Total assets:** $137.5M (USD 137,471,000)
- **Cash and equivalents:** $53.0M (USD 53,043,000)
- **Operating cash flow:** -$48.8M (USD -48,761,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $10.5M (USD 10,505,000)
- **Net income:** -$56.0M (USD -56,024,000)
- **Total assets:** $192.5M (USD 192,547,000)
- **Cash and equivalents:** $17.8M (USD 17,770,000)
- **Operating cash flow:** -$48.0M (USD -48,029,000)

## Recent SEC filings

- Form 8-K — filed 2023-03-06 — period 2023-03-03 — 8-K
- Form SC 13G — filed 2023-02-10 — KYNAM CAPITAL MANAGEMENT, LP
- Form SC 13G — filed 2023-02-10 — KYNAM CAPITAL MANAGEMENT, LP
- Form 8-K — filed 2023-01-19 — period 2023-01-18 — 8-K
- Form 10-Q — filed 2022-11-07 — period 2022-09-30 — 10-Q
- Form 8-K — filed 2022-11-07 — period 2022-11-07 — 8-K
- Form 8-K — filed 2022-08-22 — period 2022-08-16 — 8-K
- Form 10-Q — filed 2022-08-04 — period 2022-06-30 — 10-Q
- Form 8-K — filed 2022-08-04 — period 2022-08-04 — 8-K
- Form 8-K — filed 2022-06-13 — period 2022-06-08 — 8-K
- Form 8-K — filed 2022-06-03 — period 2022-06-01 — 8-K
- Form 8-K — filed 2022-05-23 — period 2022-05-23 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/concert-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology